Will Orica Limited go boom or bust? 

Orica Limited (ASX:ORI) implodes, making it a good time to buy.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Orica Limited (ASX: ORI) recently announced an impairment charge of $1.65 billion, citing a slowdown in mining as the cause. The announcement was swiftly followed by investors punishing the stock and pushing it down 17.5%. Since the sharp drop, Orica's share price has clawed back some losses and I believe it still presents a good long-term buy opportunity.

A cyclical business

Orica is an explosives and chemicals manufacturer, a highly cyclical business driven by booms in mining and construction (pun intended!). The company provides explosives and blasting systems to the defence, mining and infrastructure industries, which use Orica's product to create new mines, build new structures or for combat operations.

Orica also supplies chemicals to the mining industry that are used to extract gold and other minerals during the refining process. Accordingly, Orica's success is driven by demand for its materials, which is greatest during growth phases in any of these industries. With some analysts calling the end to a decade long mining-boom, the market's reaction to Orica's impairment suggests this is just the start of many write-downs for the high quality business. I beg to differ.

A simplified business

Orica has a history of selling its "non-core" assets; it sold paint manufacturer DuluxGroup Limited (ASX: DLX) in 2010, and its 70% stake in listed fertiliser supplier Incitec Pivot Limited (ASX: IPL) in 2006. Orica recently completed a divestment of its Orica Chemicals division to The Blackstone Group for $750 million and flagged the sale of its Minova assets acquired in 2006 "for the right price", indicating that the Orica of today is focused on one thing: explosives.

In my view, these divestments are a long-term positive for the company, as they leave the largest explosives manufacturer with a niche market to concentrate on. Whilst in the interim, Orica's earnings will need to re-base (hence the "one-off" impairment charge), over time the company should manage to generate cost efficiencies within its core business and look for reliable earnings within the explosives sector. Signs of this are already evident with management undergoing a "Transformation Program" to renegotiate long-term contracts and cut costs.

A solid income stream

In the meantime, Orica should be able to provide the patient investor with a solid income stream through dividends. The recent sale of Orica Chemicals has left Orica in a strong cash position and helped reduce debt on its balance sheet.

Management has previously indicated the potential of using surplus funds for a capital return, special dividend or share buy-back, implying shareholder-friendly initiatives in the short-term. Even if these do not eventuate, the core explosives business should generate sufficient cash flow to maintain the current dividend of 95 cents per annum. This places it on a trailing yield of 6%, providing a sustainable income in the medium term.

Foolish takeaway

Although Orica is exposed to weakness in the mining sector, current management plans should see it return to growth in the medium-term. In the interim, an investment in Orica provides a stable dividend income and the chance to be part of shareholder-friendly capital management initiatives if/when they eventuate. Accordingly, the recent price slump in Orica has provided, in my opinion, a good opportunity to buy a company with explosive potential.

Motley Fool contributor Rachit Dudhwala has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »